⌘K
Loading ticker…
As of 2026-08-25, Ultralife Corporation (ULBI) has a 3-month relative strength percentile of 41 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 52.9 (Neutral). Sector: Technology, ranked 2 of 11. Average daily range 5.3%, relative volume 0.50×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ULBI is in a stage 1 base, week 1. Currently in a 88-day base; basing ADR 5.6% (broad 5.3%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 8.0% / 5.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ULBI appears in 1 ETF as of May 2026: AVSC at 0.00% weight, $99K notional.
Held by 16 ETFs · $5M across latest filings · largest weight 0.16% (RUSC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.00% | $99K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ULBI Jan avg: 5.60% median: 4.55% win: 100% σ: 4.24% n: 4 2022-04-12 → 2026-07-31 | ULBI Feb avg: -0.32% median: -5.93% win: 25% σ: 19.99% n: 4 2022-04-12 → 2026-07-31 | ULBI Mar avg: -0.56% median: -1.52% win: 25% σ: 12.00% n: 4 2022-04-12 → 2026-07-31 | ULBI Apr avg: 4.57% median: 4.48% win: 60% σ: 18.15% n: 5 2022-04-12 → 2026-07-31 | ULBI May avg: 10.29% median: 0.24% win: 60% σ: 21.74% n: 5 2022-04-12 → 2026-07-31 | ULBI Jun avg: 4.44% median: -5.80% win: 40% σ: 20.00% n: 5 2022-04-12 → 2026-07-31 | ULBI Jul avg: 10.27% median: -1.54% win: 40% σ: 34.91% n: 5 2022-04-12 → 2026-07-31 | ULBI Aug avg: 0.42% median: -0.54% win: 50% σ: 15.33% n: 4 2022-04-12 → 2026-07-31 (current) | ULBI Sep avg: -4.03% median: -2.80% win: 25% σ: 6.99% n: 4 2022-04-12 → 2026-07-31 | ULBI Oct avg: -6.24% median: -2.03% win: 50% σ: 12.72% n: 4 2022-04-12 → 2026-07-31 | ULBI Nov avg: -10.62% median: -12.18% win: 25% σ: 8.81% n: 4 2022-04-12 → 2026-07-31 | ULBI Dec avg: -4.74% median: -5.26% win: 25% σ: 4.38% n: 4 2022-04-12 → 2026-07-31 |